Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis

The Multiple Sclerosis Outcome Assessments Consortium (MSOAC) includes representatives from advocacy organizations, Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institute of Neurological Disorders and Stroke (NINDS), academic institutions, and industry partners along...

Full description

Saved in:
Bibliographic Details
Published in:Mult Scler
Main Authors: Motl, Robert W, Cohen, Jeffrey A, Benedict, Ralph, Phillips, Glenn, LaRocca, Nicholas, Hudson, Lynn D, Rudick, Richard
Format: Artigo
Language:Inglês
Published: SAGE Publications 2017
Subjects:
Invited Reviews
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5405807/
https://ncbi.nlm.nih.gov/pubmed/28206828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458517690823
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items